Fibronectin expression in bronchopulmonary dysplasia

Area of Science:

• Neonatal lung disease
• Extracellular matrix biology
• Fibrosis research

Background:

• Bronchopulmonary dysplasia (BPD) is a chronic neonatal lung disease.
• Fibronectin (FN), an extracellular matrix protein, is elevated in BPD.
• Pulmonary FN originates from plasma and local synthesis.

Purpose of the Study:

• Identify pulmonary cells synthesizing FN.
• Quantify FN abundance in BPD lungs.
• Correlate FN levels with BPD stages.

Main Methods:

• In situ hybridization for FN mRNA.
• Immunohistochemistry for FN protein.
• Analysis of neonatal autopsy lung specimens (BPD vs. controls).

Main Results:

• FN mRNA and protein found in vascular endothelium, macrophages, fibroblasts, smooth muscle, and chondrocytes.
• Hyaline membranes showed intense FN protein staining.
• FN levels increased in early BPD, peaking in the chronic stage, and decreased in healed BPD.

Conclusions:

• Pulmonary cells, excluding airway epithelium, synthesize FN.
• Increased FN is associated with BPD progression and fibrotic changes.
• Pulmonary cell-derived FN plays a role in BPD pathogenesis.